Explore

College Student Dies from Meningococcal Disease After European Trip

College Student Dies from Meningococcal Disease After European Trip

Alexander 'Zander' Philogene, a 21-year-old college student, died shortly after showing symptoms of Meningococcal B, a disease often mistaken for the flu. Philogene, who was studying abroad in Austria, began experiencing dizziness, headaches, and shortness of breath after returning from a trip to Portugal. Despite being vaccinated, he may have contracted a new aggressive strain of the disease. His condition rapidly deteriorated, leading to cardiac arrest at an airport, and he was pronounced dead at a local hospital. Philogene's death has highlighted the dangers of meningococcal disease, which can be fatal even with treatment.

Moderna Begins Trial of mRNA Vaccine for H5N1 Bird Flu in US and UK

Moderna Begins Trial of mRNA Vaccine for H5N1 Bird Flu in US and UK

Moderna has initiated a pivotal trial for its mRNA-based vaccine targeting the H5N1 bird flu strain, with the trial taking place in both the United States and the United Kingdom. The vaccine, known as mRNA-1018, is designed to combat a new strain of the influenza virus that has significantly impacted bird populations and livestock globally, while also being responsible for hundreds of human fatalities. The trial aims to assess the vaccine's safety and immunogenicity in approximately 4,000 healthy adults aged 18 and older. This development highlights the potential of mRNA technology to revolutionize pandemic responses, building on the success of mRNA vaccines during the COVID-19 pandemic. The trial is particularly focused on recruiting participants from the poultry industry and individuals over 65, who are considered most at risk.

Bill to allow assisted dying in England and Wales is set to fall as parliamentary time runs out

Bill to allow assisted dying in England and Wales is set to fall as parliamentary time runs out

A proposed bill to allow terminally ill adults in England and Wales to choose to end their lives is set to fall Friday as parliamentary time runs out

Countries Implementing Social Media Bans for Children to Address Safety Concerns

Countries Implementing Social Media Bans for Children to Address Safety Concerns

Several countries are moving forward with legislation to ban social media access for children and teens, citing concerns over cyberbullying, addiction, mental health issues, and exposure to predators. Australia was the first to implement such a ban in December 2025, prohibiting children under 16 from using major social media platforms like Facebook, Instagram, and TikTok. Other countries, including Austria, Denmark, France, Germany, Greece, Indonesia, Malaysia, Poland, Slovenia, Spain, Turkey, and the UK, are considering or have already proposed similar measures. These bans often include age verification requirements to ensure compliance. Critics argue that these measures may infringe on privacy and fail to address the realities of digital engagement among younger generations.

Time runs out for assisted dying bill for England and Wales

Time runs out for assisted dying bill for England and Wales

A proposed bill allowing terminally ill adults in England and Wales to end their lives has failed

Bill to allow assisted dying in England and Wales fails as parliamentary time runs out

Bill to allow assisted dying in England and Wales fails as parliamentary time runs out

A proposed bill to allow terminally ill adults in England and Wales to choose to end their lives has failed as parliamentary time ran out

Texas Biomed Launches $2 Million Fund to Boost Tuberculosis Research and Treatment

Texas Biomed Launches $2 Million Fund to Boost Tuberculosis Research and Treatment

Texas Biomedical Research Institute has announced the establishment of a $2 million Tuberculosis Innovation and Technology Fund. This initiative is supported by philanthropic investments aimed at accelerating research and development of therapies for tuberculosis (TB), the world's deadliest infectious disease. The fund will be used to recruit top scientific talent and acquire advanced research technologies, such as the Akoya Phenocycler system and the Emulate Orb and Zoe Culture module system. These tools will enhance the study of disease mechanisms and aid in the development of new treatments. Texas Biomed, which hosts a premier NIH-funded TB research center, aims to strengthen its capabilities and contribute to global efforts to combat TB, which remains a significant health concern in Texas.

Paxlovid Accelerates COVID-19 Recovery but Fails to Lower Hospitalization Rates in Vaccinated Patients

Paxlovid Accelerates COVID-19 Recovery but Fails to Lower Hospitalization Rates in Vaccinated Patients

Recent research into Paxlovid, an antiviral medication developed by Pfizer, indicates that while it speeds up recovery in high-risk COVID-19 patients, it does not significantly reduce hospital admissions among vaccinated individuals. This conclusion is based on findings from two open-label trials, the UK 'PANORAMIC' trial and the Canadian 'CanTreatCOVID' trial, involving over 4,200 participants. These trials included individuals aged 50 and above or younger individuals with conditions like diabetes or asthma. Participants were either given Paxlovid or received usual care, with the majority having been vaccinated against COVID-19. The trials showed that Paxlovid reduced the median recovery time significantly compared to usual care. However, the rate of hospitalization or death did not differ substantially between the Paxlovid group and the usual care group.

Silent Measles Spread in US Threatens Elimination Status

Silent Measles Spread in US Threatens Elimination Status

Newer testing methods have revealed a significant silent spread of measles in the United States, particularly in Utah and Arizona, threatening the country's measles elimination status. Reports indicate that measles cases have topped 1,700 in the first four months of the year, with a major outbreak in a community spanning northern Arizona and southern Utah. The outbreak, which has grown to over 600 reported cases, is linked to low vaccination rates and distrust in vaccines within certain communities. The US Centers for Disease Control and Prevention (CDC) is using molecular evidence to trace the origins and true size of the outbreak, which may have started much earlier than initially reported.

Domes Resorts Appoints Craig Jeffs as Head of Sales for UK Ireland Amid Expansion

Domes Resorts Appoints Craig Jeffs as Head of Sales for UK Ireland Amid Expansion

Domes Resorts Appoints Craig Jeffs as Head of Sales for UK Ireland Amid Expansion

Craig Jeffs Appointed Head of Sales for UK Ireland at Domes Amidst Expansion

Craig Jeffs Appointed Head of Sales for UK Ireland at Domes Amidst Expansion

Craig Jeffs Appointed Head of Sales for UK Ireland at Domes Amidst Expansion

Moderna Begins Pivotal Trial for H5N1 Bird Flu Vaccine in US and UK

Moderna Begins Pivotal Trial for H5N1 Bird Flu Vaccine in US and UK

Moderna has initiated a large-scale phase 3 trial for its mRNA-based vaccine, mRNA-1018, targeting the H5N1 bird flu virus. This trial involves around 4,000 healthy adults in the US and UK, focusing on poultry industry workers and individuals over 65, who are at higher risk. The H5N1 strain has been a significant threat to bird populations globally and poses a potential pandemic risk to humans. The trial aims to assess the vaccine's safety and immunogenicity, with Moderna planning to combine results with data from its seasonal flu vaccine for regulatory filings. The Coalition for Epidemic Preparedness Innovations (CEPI) is supporting the project, emphasizing the importance of mRNA technology in pandemic preparedness.